Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-25-000293
Filing Date
2025-02-25
Accepted
2025-02-25 13:29:46
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3898
  Complete submission text file 0001731122-25-000293.txt   5717
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELOMIR PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address
Fuentes Nathen (Reporting) CIK: 0002005072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38758 | Film No.: 25661384